Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119657754 | 11965775 | 4 | F | 20160801 | 20160127 | 20160803 | EXP | JP-ROCHE-1701041 | ROCHE | , IWASA S, FUKAHORI M, SUDO K, SASAKI Y, SHOJI H, HONMA Y, OKITA N, TAKASHIMA A, HAMAGUCHI T, BOKU N, SHIMADA Y, HONDA K, YAMADA T AND YAMADA Y. A PHASE I STUDY OF THE COMBINATION OF PANITUMUMAB AND BEVACIZUMAB IN KRAS WILD-TYPE COLORECTAL CANCER PATIENTS PREVIOUSLY TREATED WITH FLUOROPYRIMIDINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB. CANCER CHEMOTHERAPY AND PHARMACOLOGY 2016 JUN 20;:1-9. | 72.00 | YR | F | Y | 0.00000 | 20160803 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119657754 | 11965775 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous drip | ON DAY1 | 125085 | 5 | MG/KG | QOW | |||||||
| 119657754 | 11965775 | 2 | SS | PANITUMUMAB | PANITUMUMAB | 1 | Intravenous drip | ON DAY1 | U | 0 | 6 | MG/KG | QOW | ||||||
| 119657754 | 11965775 | 3 | C | MINOCYCLINE HYDROCHLORIDE. | MINOCYCLINE HYDROCHLORIDE | 1 | Oral | 0 | 100 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119657754 | 11965775 | 1 | Colorectal cancer |
| 119657754 | 11965775 | 2 | Colorectal cancer |
| 119657754 | 11965775 | 3 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119657754 | 11965775 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119657754 | 11965775 | Dermatitis acneiform |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |